Viewing StudyNCT00110422



Ignite Creation Date: 2024-05-05 @ 11:44 AM
Last Modification Date: 2024-10-26 @ 9:12 AM
Study NCT ID: NCT00110422
Status: COMPLETED
Last Update Posted: 2011-04-15
First Post: 2005-05-09

Brief Title: Irbesartan in the Treatment of Hypertensive Patients With Metabolic Syndrome
Sponsor: Bristol-Myers Squibb
Organization: Bristol-Myers Squibb

Organization Data

Organization: Bristol-Myers Squibb
Class: INDUSTRY
Study ID: CV131-186
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Bristol-Myers Squibb
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
Sanofi INDUSTRY